Ahmadi, K., Farasat, A., Rostamian, M., Johari, B., & Madanchi, H. (2021). Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: An in silico drug repurposing study. J Biomol Struct Dyn.
Chicago Stili AlıntıAhmadi, Khadijeh, Alireza Farasat, Mosayeb Rostamian, Behrooz Johari, ve Hamid Madanchi. "Enfuvirtide, an HIV-1 Fusion Inhibitor Peptide, Can Act As a Potent SARS-CoV-2 Fusion Inhibitor: An in Silico Drug Repurposing Study." J Biomol Struct Dyn 2021.
MLA AlıntıAhmadi, Khadijeh, et al. "Enfuvirtide, an HIV-1 Fusion Inhibitor Peptide, Can Act As a Potent SARS-CoV-2 Fusion Inhibitor: An in Silico Drug Repurposing Study." J Biomol Struct Dyn 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..